Skip to main content

Animations

MJFF Publications

1491 - 1500 of 6570 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2024
  • 2024
  • 2021
  • 2016
  • 2023
  • 2022
  • 2019
  • Summary Details
    OPEN
    Title: Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105567
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Deep-learning segmentation of the substantia nigra from multiparametric MRI: Application to Parkinson’s disease
    Journal Name: Imaging Neuroscience
    Publisher: MIT Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1162/imag.a.158
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/psp4.70000
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-240213
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Blood‐based multivariate methylation risk score for cognitive impairment and dementia
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14061
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28886
    Citation Count: 22
  • Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
    2016
    Summary Details
    OPEN
    Title: Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26754
    Citation Count: 150
  • Summary Details
    OPEN
    Title: Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in Isolated Rapid Eye Movement Sleep Behavior Disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29306
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®
    Journal Name: European Radiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00330-021-08385-9
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-019-09250-y
    Citation Count: 24
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.